Fujiki N - Search Results

1

Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.

Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, Nishino S. Yoshida Y, et al. Among authors: fujiki n. Eur J Neurosci. 2001 Oct;14(7):1075-81. doi: 10.1046/j.0953-816x.2001.01725.x. Eur J Neurosci. 2001. PMID: 11683899

2

Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats.

Yoshida Y, Fujiki N, Maki RA, Schwarz D, Nishino S. Yoshida Y, et al. Among authors: fujiki n. Neurosci Lett. 2003 Aug 7;346(3):182-6. doi: 10.1016/s0304-3940(03)00571-8. Neurosci Lett. 2003. PMID: 12853114

3

Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog.

Fujiki N, Yoshida Y, Ripley B, Mignot E, Nishino S. Fujiki N, et al. Sleep. 2003 Dec 15;26(8):953-9. doi: 10.1093/sleep/26.8.953. Sleep. 2003. PMID: 14746374

4

Neuropeptides as possible targets in sleep disorders.

Nishino S, Fujiki N. Nishino S, et al. Among authors: fujiki n. Expert Opin Ther Targets. 2007 Jan;11(1):37-59. doi: 10.1517/14728222.11.1.37. Expert Opin Ther Targets. 2007. PMID: 17150033 Review.

5

Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.

Fujiki N, Nishino S. Fujiki N, et al. CNS Neurol Disord Drug Targets. 2007 Feb;6(1):45-62. doi: 10.2174/187152707779940781. CNS Neurol Disord Drug Targets. 2007. PMID: 17305553 Review.

6

Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation.

Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. Fujiki N, et al. Neuroreport. 2001 Apr 17;12(5):993-7. doi: 10.1097/00001756-200104170-00026. Neuroreport. 2001. PMID: 11303775

7

Hypocretin levels in sporadic and familial cases of canine narcolepsy.

Ripley B, Fujiki N, Okura M, Mignot E, Nishino S. Ripley B, et al. Among authors: fujiki n. Neurobiol Dis. 2001 Jun;8(3):525-34. doi: 10.1006/nbdi.2001.0389. Neurobiol Dis. 2001. PMID: 11442359

8

Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.

Nishino S, Fujiki N, Ripley B, Sakurai E, Kato M, Watanabe T, Mignot E, Yanai K. Nishino S, et al. Among authors: fujiki n. Neurosci Lett. 2001 Nov 9;313(3):125-8. doi: 10.1016/s0304-3940(01)02270-4. Neurosci Lett. 2001. PMID: 11682143

9

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, Di Monte D, Dohi K, Melberg A, Lammers GJ, Nishida Y, Roelandse FW, Hungs M, Mignot E, Nishino S. Ripley B, et al. Among authors: fujiki n. Neurology. 2001 Dec 26;57(12):2253-8. doi: 10.1212/wnl.57.12.2253. Neurology. 2001. PMID: 11756606

10

CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.

Nishino S, Kanbayashi T, Fujiki N, Uchino M, Ripley B, Watanabe M, Lammers GJ, Ishiguro H, Shoji S, Nishida Y, Overeem S, Toyoshima I, Yoshida Y, Shimizu T, Taheri S, Mignot E. Nishino S, et al. Among authors: fujiki n. Neurology. 2003 Sep 23;61(6):823-5. doi: 10.1212/01.wnl.0000081049.14098.50. Neurology. 2003. PMID: 14504329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page